DME Drugs Equally Effective at 2 Years and other top stories.

• DME Drugs Equally Effective at 2 Years

  Three anti-VEGF therapies remained equal at improving vision for patients with diabetic macular edema (DME) in the 2-year results of the head-to-head Protocol T trial, researchers reported. But 1-year findings that aflibercept (Eylea) outperformed both bevacizumab (Avastin) and ranibizumab (Lucentis) in those with worse baseline vision (20/50 or worse) didn't hold up; aflibercept still beat out bevacizumab in these patients, but it no longer topped ranibizumab. Also, serious adverse events by o..

  >> view original



• Baby in "his last days" receives life-saving heart transplant

  A 7-month-old boy from Alaska with a failing heart was days away from death when his family received a call that a desperately needed heart transplant had arrived.Lincoln Seay was born with a rare and severe heart defect that caused all his organs to develop on the opposite side of his body. His family had been waiting for a pediatric transplant since November -- which doctors feared would come too late. "He was right on the edge," Dr. D. Michael McMullan, Seattle Children's surgical director o..

  >> view original

Police investigating 3 fatally shot in Fort Wayne, Ind., home .	Trump wins Christie backing, struts toward Super Tuesday .
Three people found dead inside Fort Wayne home .	How To Get Started With Accelerated Mobile Pages (AMP) .